“
TL;DR
The review outlines various classes of bioactive compounds and nanocarriers, including lipid-based systems noted for their relative safety.
Materials · 2 authors, 2 centres
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
The review outlines various classes of bioactive compounds and nanocarriers, including lipid-based systems noted for their relative safety.
The review outlines various classes of bioactive compounds and nanocarriers, including lipid-based systems noted for their relative safety. A major focus is on safety and toxicity, discussing nanotoxicology, the influence of physicochemical properties, and *in vivo* findings suggesting nanoparticles around 40–70 nm may damage organs. The review concludes that while OBNs are promising, overcoming these material and production challenges is essential for their future application.